Adcetris

Medicinal product

(Invented) name

Adcetris

Active substance (s)

Brentuksimabas vedotinas

Strength

50 mg

Pharmaceutical form

milteliai infuzinio tirpalo koncentratui

Route (s) of administration

leisti į veną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

L01FX05, brentuximab vedotin

Marketing authorisation holder

UAB Lex ano, Lietuva

Date of authorisation

2017-02-14

Date of renewal

Documents

Search in EMA Europe

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

8(3)

Procedure number

Marketing authorisation procedure

CR-Lygiagretus platinimas

Qualitative and quantitative composition

Powder for concentrate for solution for infusion	1 vnt.
Brentuksimabas vedotinas	50 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
67759	82316	1082316	flakonas	N1		Receptinis	EU/1/12/794/001	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2017-02-14	Registruotas